首页> 外文期刊>Antimicrobial agents and chemotherapy. >Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
【24h】

Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.

机译:门诊患者对氟喹诺酮类耐药的大肠杆菌尿液分离株通常具有多重耐药性:来自北美泌尿道感染合作联盟-喹诺酮耐药性研究的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

Ciprofloxacin-resistant Escherichia coli isolates (n = 1,858) from outpatient midstream urine specimens at 40 North American clinical laboratories in 2004 to 2005 were frequently resistant to ampicillin (79.8% of isolates) and trimethoprim-sulfamethoxazole (66.5%); concurrent resistance to cefdinir (9.0%) or nitrofurantoin (4.0%) was less common. Only 10.8% of isolates were resistant to ciprofloxacin alone. Fluoroquinolone-resistant isolates of E. coli from urine were frequently multidrug resistant.
机译:2004年至2005年在北美40个临床实验室的门诊中流尿液样本中,对环丙沙星耐药的大肠杆菌分离株(n = 1858)经常对氨苄西林(占分离株的79.8%)和甲氧苄氨嘧啶-磺胺甲恶唑(66.5%)耐药;对头孢地尼(9.0%)或呋喃妥因(4.0%)的同时耐药性较不常见。仅10.8%的分离株仅对环丙沙星耐药。尿液中对氟喹诺酮类耐药的大肠杆菌分离株通常具有多重耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号